A systematic review of the use of rituximab as induction therapy in renal transplantation
Author:
Publisher
Elsevier BV
Subject
Transplantation
Reference56 articles.
1. Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes;Tedder;Eur J Immunol,1986
2. Pharmacodynamics of rituximab in kidney allotransplantation;Genberg;Am J Transplant,2006
3. In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody;Sidner;Hum Antibodies,2004
4. Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients;Kopchaliiska;Transplantation,2009
5. Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients;Zarkhin;Transplantation,2011
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Extracorporeal Photopheresis Improves Graft Survival in a Full-Mismatch Rat Model of Kidney Transplantation;Transplant International;2023-01-12
2. Investigational drugs for the treatment of kidney transplant rejection;Expert Opinion on Investigational Drugs;2022-10-03
3. Transplant Trial Watch;Transplant International;2022-03-15
4. CTOTC‐08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients;American Journal of Transplantation;2021-11-05
5. What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?;Transplantation;2021-01-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3